Online citations, reference lists, and bibliographies.
← Back to Search

Effects Of Efavirenz Binding On The Subunit Equilibria Of HIV-1 Reverse Transcriptase.

C. F. Venezia, Kathryn J. Howard, M. E. Ignatov, Leslie A Holladay, M. Barkley
Published 2006 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Recent studies showed that nonnucleoside reverse transcriptase inhibitors (NNRTIs) have variable effects on dimerization of p66 and p51 subunits of HIV-1 reverse transcriptase (RT). Efavirenz, one of three NNRTIs currently used in highly active anti-retroviral therapy, enhances subunit dimerization. Sedimentation equilibrium experiments on each subunit and equimolar mixtures of both subunits were used to measure dissociation constants for the three coupled dimerization reactions of RT in the absence and presence of saturating concentrations of the drug. The dimerization constants of the p51/p51 homodimer, the p66/p66 homodimer, and the p66/p51 heterodimer increased 600-, 50-, and 25-fold, respectively, upon binding of efavirenz. The effects of NNRTIs on RT dimerization are consistent with a thermodynamic linkage between subunit association/dissociation and inhibitor binding. Analysis of crystal structures of the p66/p51 heterodimer reveals that efavirenz binding induces small structural changes at the dimer interface.



This paper is referenced by
10.1016/j.antiviral.2009.07.021
Solution characterization of [methyl-(13)C]methionine HIV-1 reverse transcriptase by NMR spectroscopy.
X. Zheng (2009)
10.1016/j.ab.2009.02.019
Separation of protein oligomers by blue native gel electrophoresis.
Valerie A. Braz (2009)
10.1016/j.virusres.2008.01.002
Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors.
N. Sluis-Cremer (2008)
10.1021/bi9010495
Kinetics of association and dissociation of HIV-1 reverse transcriptase subunits.
Carl F Venezia (2009)
10.1074/jbc.M802199200
A New Generation of Peptide-based Inhibitors Targeting HIV-1 Reverse Transcriptase Conformational Flexibility*
A. Agopian (2009)
10.3390/biom3040889
Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
Grant Schauer (2013)
10.1021/bi9010495
Kinetics of association and dissociation of HIV-1 reverse transcriptase subunits.
C. F. Venezia (2009)
10.1021/bi101480z
Efavirenz binding site in HIV-1 reverse transcriptase monomers.
Valerie A. Braz (2010)
10.1002/prot.24594
The p66 immature precursor of HIV‐1 reverse transcriptase
Naima G. Sharaf (2014)
10.1038/nsmb.1937
Initiation complex dynamics direct the transitions between distinct phases of early HIV reverse transcription
S. Liu (2010)
10.1042/BCJ20170480
Identification of drivers for the metamorphic transition of HIV-1 reverse transcriptase.
X. Zheng (2017)
10.1039/C1MD00162K
Key interactions of the mutant HIV-1 reverse transcriptase/efavirenz: an evidence obtained from ONIOM method
Pornthip Boonsri (2011)
10.1016/j.virol.2011.11.001
Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging.
Chien-Cheng Chiang (2012)
10.4137/DTI.S0
Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
J. Wapling (2007)
10.1186/1742-4690-7-89
Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease
D. Jochmans (2010)
10.1371/journal.pone.0006108
The Y271 and I274 Amino Acids in Reverse Transcriptase of Human Immunodeficiency Virus-1 Are Critical to Protein Stability
H. Zhang (2009)
10.1021/acs.analchem.5b00372
Differential isotopic enrichment to facilitate characterization of asymmetric multimeric proteins using hydrogen/deuterium exchange mass spectrometry.
D. Goswami (2015)
Solution NMR studies of HIV-1 reverse transcriptase
Naima G. Sharaf (2017)
10.1007/978-1-4614-7291-9_8
Targeting Small Molecules and Peptides to the p66-p51 Reverse Transcriptase Interface
Daouda Mousatpha Abba Moussa (2013)
10.1093/infdis/jir385
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.
R. Paredes (2011)
10.1016/j.jmb.2018.02.027
Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase.
T. Ilina (2018)
Binding of the Nonnucleoside Reverse Transcriptase Inhibitor Efavirenz to HIV-1 Reverse Transcriptase Monomers and Dimers
Valerie A. Braz (2009)
10.1371/journal.ppat.0020119
Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1 Gag-Pol
A. Figueiredo (2006)
10.1021/bi902116z
Homodimerization of the p51 subunit of HIV-1 reverse transcriptase.
X. Zheng (2010)
10.1021/jp308674g
Binding kinetics and affinities of heterodimeric versus homodimeric HIV-1 reverse transcriptase on DNA-DNA substrates at the single-molecule level.
Ryan A Marko (2013)
10.1128/JVI.01532-09
A Single Amino Acid Substitution in HIV-1 Reverse Transcriptase Significantly Reduces Virion Release
Chien-Cheng Chiang (2009)
10.1016/j.bpc.2011.05.014
The use of analytical sedimentation velocity to extract thermodynamic linkage.
J. L. Cole (2011)
10.1074/mcp.M114.041087
Kinase Substrate Sensor (KISS), a Mammalian In Situ Protein Interaction Sensor*
S. Lievens (2014)
Mechanisms by which Nonnucleoside Reverse Transcriptase Inhibitors Block HIV-1 Replication Alone and in Combination with other Reverse Transcriptase Inhibitors
J. Radzio (2010)
Computational Modeling of Substitution Effect on HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Kier- Hall Electrotopological State (E-state) Indices
B. Press (2008)
10.1038/nature06941
Dynamic binding orientations direct activity of HIV reverse transcriptase
E. Abbondanzieri (2008)
10.1002/prot.25383
The HIV‐1 p66 homodimeric RT exhibits different conformations in the binding‐competent and ‐incompetent NNRTI site
Naima G. Sharaf (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar